HOME >> BIOLOGY >> NEWS
Fe-TAML(R) activators developed at Carnegie Mellon decontaminate anthrax simulant

NEW YORK-Carnegie Mellon University scientists today announced that one of their powerful, environmentally friendly catalysts called Fe-TAMLR activators has the potential to become an important cleanup tool for anthrax contamination.

The Fe-TAML activator used with hydrogen peroxide can substantially decontaminate a cultured, benign simulant of anthrax, they said. This anthrax simulant is commonly used in the laboratory testing of agents designed to eliminate its more deadly cousin, which is considered a significant biological warfare and terrorist threat.

The results of initial laboratory investigations are being presented by Carnegie Mellon graduate student Deboshri Banerjee on Wednesday, Sept. 10, in New York City at the 226th annual meeting of the American Chemical Society (paper 158, "Deactivation of bacterial spores using TAML-peroxide technology towards developing an efficient process for water disinfection," Industrial & Engineering Chemistry Division). The National Science Foundation funded this research.

"In our laboratory tests, Fe-TAMLs are highly promising in cleaning up an anthrax simulant, Bacillus atrophaeus," said Terry Collins, the Thomas Lord Professor of Chemistry at Carnegie Mellon and the chief researcher on the Fe-TAML project. "These results indicate the enormous potential of Fe-TAMLs to kill the lethal strain of anthrax and to eradicate other water-borne infectious microbes that account for significant death and disability worldwide."

A common simulant for anthrax testing, Bacillus atrophaeus is a species of spore closely related to Bacillus anthracis, the spore that causes debilitating, often fatal anthrax. According to the Center for Disease Control (CDC), anthrax is an agent with recognized bioterrorism potential. The CDC classifies it as a Category A agent, meaning that it poses the greatest possible threat to public health, that it may spread across a large area quickly and that its pr
'"/>

Contact: Lauren Ward
wardle@andrew.cmu.edu
412-268-7761
Carnegie Mellon University
10-Sep-2003


Page: 1 2 3

Related biology news :

1. Fe-TAML(R) activators developed at Carnegie Mellon remove recalcitrant sulfur from automotive fuels
2. Fe-TAML(R) activators developed at Carnegie Mellon break down toxic pesticides
3. Fe-TAML(R) activators developed at Carnegie Mellon help cleanup paper and wood pulp manufacturing
4. Fe-TAML(R) activators developed at Carnegie Mellon decolorize textile mill wastewater
5. Computer database being developed at Temple will allow for better inventory of chemicals
6. New software developed at Rensselaer predicts promising ingredients for new drugs
7. New imaging technique developed to identify breast cancer
8. Portable kidney dialysis machine developed
9. New method of identifying and isolating stem cells developed
10. Study calls for cheaper antitoxins for plant poisoning in less-developed countries
11. Drug developed for rare disease may help millions more as treatment for cancer, autoimmune diseases

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/28/2017)... PUNE, India , March 28, 2017 ... (Analog, IP, Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), ... Maintenance), Vertical, and Region - Global Forecast to 2022", ... 30.37 Billion in 2016 and is projected to reach ... 15.4% between 2017 and 2022. The base year considered ...
Breaking Biology News(10 mins):
(Date:5/22/2017)... , ... May 22, 2017 , ... ... with other leaders of the Maryland Biohealth community in developing and issuing recommendations ... Top 3 U.S. BioHealth Innovation Hub by 2023. , The ...
(Date:5/21/2017)... (PRWEB) , ... May 20, 2017 , ... ... that helps avoid the lengthy trial and error process by finding the right ... It can also strengthen the doctor-patient relationship through a personalized approach to treatment. ...
(Date:5/18/2017)... ... May 18, 2017 , ... ... April 28, 2017 at the Prince Of Wales Private Hospital. The procedure was ... level C6-C7. The patient failed conservative treatments prior to undergoing surgery. , The ...
(Date:5/18/2017)... ... 17, 2017 , ... NDA Partners Chairman Carl Peck, MD , announced ... Laboratories and President of Pharmaceutical Development Business Unit of Cardinal Health, has joined the ... Health, he was former Chief Operating Officer at Anaborex, Senior VP and General Manager ...
Breaking Biology Technology:
Cached News: